
Biomarker-Adapted Treatment Effective in High-Risk LBCL
Stratifying patients based on biological risk factors is a feasible and effective way to achieve high rates of survival among patients with large B-cell lymphoma (LBCL), a new study found.1 The report, published in the journal HemaSphere, also found that …